For more information about Qutenza®, please call   and select from the following options:

Press Option 1 to:
  • Report Adverse Events
  • Report Product Quality Complaints
  • Obtain Medical Information About Qutenza®
Press Option 2 for:
  • Questions on the Administration of Qutenza® if you are a Healthcare Provider
Press Option 3 for:
  • Qutenza® Reimbursement Support Services
  • Patient Access Matters Concerning Qutenza®
  • Distribution Information
Press Option 4 for:
  • Product Ordering for Authorized Distributors

Healthcare Professional Resources:

The following resources are for HCP usage only.

Patient Resources:

Patient Resources:

Support Forms:

Indication

Qutenza® is indicated for the management of neuropathic pain associated with postherpetic neuralgia.

IMPORTANT SAFETY INFORMATION

Treatment with Qutenza® must be performed only by a healthcare provider. You should never apply or remove Qutenza® yourself.

Warnings and Precautions:

Side Effects:

In clinical studies, the most common drug-related side effects of Qutenza®, which occurred in 5% or more of patients, included redness, pain, itching, or small bumps where Qutenza® was applied, and nausea. You should tell your doctor if any side effects bother you or do not go away.

Adverse Event Reporting:

Physicians, other health care providers and patients are encouraged to voluntarily report adverse events involving drugs or medical devices. To make a report you can:

For more information, ask your healthcare provider or pharmacist.

Please click here for full Prescribing Information.

Carton with one patch + cleansing gel: NDC number #10144-0928-01

Carton with two patches + cleansing gel: NDC number #10144-0929-01

Qutenza® is a registered trademark of Averitas Pharma, Inc.

© 2018 Averitas Pharma, Inc. All rights reserved.


This site is intended for residents of the United States only.